D-0265-2025 Class II Ongoing

Recalled by Aspen Biopharma Labs Pvt., Ltd. — Medchal Malkajgiri

FDA drug recall D-0265-2025 was initiated by Aspen Biopharma Labs Pvt., Ltd. on Feb 7, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 4.0 kg.

Recall details

Product Type
Drugs
Report Date
Mar 19, 2025
Initiation Date
Feb 7, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4.0 kg

Product description

Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.

Reason for recall

CGMP Deviations

Distribution pattern

Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)

Code information

Lot Number: HAVZC0020922, exp. date AUG-2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0265-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0265-2025. Report a data issue: hello@regdatalab.com.